Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02606305
Title Study of IMGN853 in Comb. With Bevacizumab, Carboplatin or PLD in Adults With FRa + Adv. EOC, Primary Peritoneal, Fallopian Tube, or Endometrial Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors ImmunoGen, Inc.
Age Groups: adult
Covered Countries USA | ESP | CAN | BEL

No variant requirements are available.